TrialBMC cancer2018

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial.

Yannan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.